Nano X Imaging Ltd (NNOX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Nano X Imaging Ltd stock (NNOX) is currently trading at $2.29. Nano X Imaging Ltd PS ratio (Price-to-Sales) is 13.80. Analyst consensus price target for NNOX is $7.40. WallStSmart rates NNOX as Sell.
- NNOX PE ratio analysis and historical PE chart
- NNOX PS ratio (Price-to-Sales) history and trend
- NNOX intrinsic value — DCF, Graham Number, EPV models
- NNOX stock price prediction 2025 2026 2027 2028 2029 2030
- NNOX fair value vs current price
- NNOX insider transactions and insider buying
- Is NNOX undervalued or overvalued?
- Nano X Imaging Ltd financial analysis — revenue, earnings, cash flow
- NNOX Piotroski F-Score and Altman Z-Score
- NNOX analyst price target and Smart Rating
Nano X Imaging
📊 No data available
Try selecting a different time range
Smart Analysis
Nano X Imaging Ltd (NNOX) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Nano X Imaging Ltd (NNOX) Key Strengths (1)
Trading at 1.07x book value, attractively priced
Supporting Valuation Data
Nano X Imaging Ltd (NNOX) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Very expensive at 13.8x annual revenue
Micro-cap company with very limited liquidity and high volatility
Low institutional interest, mostly retail-driven
Solid revenue growth at 13.70% per year
Supporting Valuation Data
Nano X Imaging Ltd (NNOX) Detailed Analysis Report
Overall Assessment
This company scores 24/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 1 register as strengths (avg 8.0/10) while 6 fall into concern territory (avg 2.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book. Valuation metrics including Price/Book (1.07) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Price/Sales. Some valuation metrics including Price/Sales (13.80) suggest expensive pricing. Growth concerns include Revenue Growth at 13.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -34.70%, Operating Margin at -413.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -34.70% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 13.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
NNOX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
NNOX's Price-to-Sales ratio of 13.80x trades at a deep discount to its historical average of 42.26x (8th percentile). The current valuation is 89% below its historical high of 120.04x set in May 2023, and 10% above its historical low of 12.6x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~30.3x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Nano X Imaging Ltd (NNOX) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Nano X Imaging Ltd operates as a stable business with moderate growth and solid fundamentals. Revenue reached 12M with 14% growth year-over-year.
Key Findings
Debt-to-equity ratio of 0.05 indicates a conservative balance sheet with 45M in cash.
Spending 37% of revenue (5M) on R&D, reinforcing its commitment to innovation and future growth.
Free cash flow is -14M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Nano X Imaging Ltd.
Bottom Line
Nano X Imaging Ltd offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 11:32:47 AM
About Nano X Imaging Ltd(NNOX)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Nano-X Imaging Ltd., a development-stage company, develops, produces and markets digital X-ray source technology for the medical imaging industry globally. The company is headquartered in Neve Ilan, Israel.